Viewing Study NCT05384756


Ignite Creation Date: 2025-12-24 @ 11:24 PM
Ignite Modification Date: 2025-12-25 @ 9:09 PM
Study NCT ID: NCT05384756
Status: RECRUITING
Last Update Posted: 2024-12-31
First Post: 2022-05-03
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: TMLI and Alemtuzumab for Treatment of Sickle Cell Disease
Sponsor: City of Hope Medical Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module